Boehringer Ingelheim Pharmaceuticals Inc. and BioImage AS sign licensing deal on Redistribution® Technology
The Redistribution® patent portfolio covers a broad range of methods aimed at studying intracellular signalling events. The Redistribution® technology enables high throughput screening on a number of drug discovery live cell screening applications, such as protein translocations, receptor internalizations, protein trafficking, secretions, etc. BioImage is presently out licensing the portfolio to a number of leading companies within the life science industry.
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.